Project title: Active targeted drug delivery systems based on peptide-functionalized magnetic nanoparticles for the treatment of inner ear diseases (TargEar)
FINANCING CONTRACT no 15 ⁄ 2020
Promoter: “Apollonia” University of Iasi, Romania
Partners: P1 – Institute of Biological Research – INCDSB, Iasi, Romania
Funding: Norway Grants NO 2014-2021 and the Government of Romania
Name of the Program: Research – RO 02
Total value of public funding: 1.163.984 euro (5.624.137,90 Lei)
Project start date: 01.09.2020
Project duration: 36 months
The European Economic Area (EEA) and Norway Grants represent the contribution of Iceland, Liechtenstein and Norway to reducing economic and social disparities in the European Economic Area and to strengthening bilateral relations with the 15 beneficiary countries in Eastern and Southern Europe and the Baltic states.
These financial mechanisms are based on the European Economic Area Agreement which reunites the EU member states and Iceland, Liechtenstein and Norway as equal partners in the internal market.
In total, the three countries have provided €3.3 billion through consecutive grant schemes between 1994 and 2014. A further €2.8 billion has been made available in the 2014-2021 funding period. The EEA grants are jointly funded by all the three donors, while the Norway Grants are funded exclusively by Norway and are available in the 13 countries having joined the EU after 2003.
Funding is channelled through financing programmes, under specific priority sectors, while the areas, objectives and expected results are established with each beneficiary country.
Working together for a green, competitive and inclusive Europe